Article
2023 USPSTF mammography age to start screening in average-risk patients: What’s new is old again
Article
Does tamoxifen use increase the risk of endometrial cancer in premenopausal patients?
In a large, nationwide retrospective longitudinal cohort study that examined the occurrence of endometrial cancer and other uterine pathology in...
Article
Progress in breast cancer screening over the past 50 years: A remarkable story, but still work to do
Expert perspective on the myriad factors that play a role in breast cancer screening recommendations and the guidelines to consider when engaging...
Article
Late-onset recurrence in breast cancer: Implications for women’s health clinicians in survivorship care
Data show that late-onset recurrence is more likely among patients with an initial tumor size >2 cm, lymph node–positive disease, and hormone...
Article
It’s not time to abandon routine screening mammography in average-risk women in their 40s
Results of a new mammography screening study inform us that routine breast cancer risk assessment to facilitate patient...
Article
Should supplemental MRI be used in otherwise average-risk women with extremely dense breasts?
Recent data show that supplemental MRI screening in women with extremely dense breasts and negative screening mammograms decreases the rate of...
Article
Should breast cancer screening guidelines be tailored to a patient’s race and ethnicity?
Yes. Because women of minor ity races/ethnicities have an earlier age of onset of breast cancer (45 to 50 years) compared with...
Article
How does oral contraceptive use affect one’s risk of ovarian, endometrial, breast, and colorectal cancers?
Oral contraceptives (OCs) are associated with a decreased risk of ovarian and endometrial cancers across multiple modifiable...
Article
Does hormonal contraception increase the risk of breast cancer?
These experts analyze the data from a recent large study and provide counseling points for your patients
Article
Breast cancer screening: Is the controversy of benefits versus harms resolved?
Researchers recently described which national mammography screening strategy most effectively reduced breast cancer mortality and resulted in most...
Article
Does extending aromatase-inhibitor use from 5 to 10 years benefit menopausal women with hormone-positive breast cancer?
In terms of improving the 5-year disease-free survival (DFS) rate, yes, according to results of a randomized study that compared extended...
News
Based on interval cancer rates, which women with dense breasts are most likely to benefit from supplemental imaging?
The authors of this prospective study involving more than 350,000 patients observed high interval cancer rates for women with 5-year breast cancer...
News
Is supplemental ultrasonography a valuable addition to breast cancer screening for women with dense breasts?
The benefit is small and the cost is high, according to this comparative modeling study.
News
Which women are most likely to die from breast cancer—those screened annually starting at age 40, biennially starting at age 50, or not at all?
Most deaths from breast cancer occur in women who are unscreened, according to this review of medical records and death data from two large...
News
UPDATE ON BREAST HEALTH
A look at findings from the estrogen-alone arm of the WHI, chemoprophylaxis for high-risk women, and fertility preservation for young breast...